What is the recommended duration of high‑dose aspirin for acute migratory polyarthritis in rheumatic fever and how long should low‑dose aspirin be continued for secondary prophylaxis?

Aspirin Duration in Rheumatic Fever Arthritis

For acute migratory polyarthritis in rheumatic fever, initiate high-dose aspirin at 80–100 mg/kg/day divided into four doses and continue until the patient has been afebrile for 48–72 hours, then transition to low-dose aspirin 3–5 mg/kg/day once daily for a total treatment duration of 12 weeks. 1, 2

Acute Phase: High-Dose Aspirin (Anti-inflammatory)

Initial dosing and duration:

• Start 80–100 mg/kg/day divided into four daily doses immediately upon diagnosis 1
• Continue high-dose therapy until the patient has been afebrile for 48–72 hours 1, 3
• Some protocols extend high-dose treatment to day 14 of illness plus 48–72 hours after fever cessation 1
• The response to high-dose aspirin in rheumatic fever arthritis is characteristically prompt and dramatic, typically within 24–48 hours 3

Key clinical point: The dramatic response to aspirin is so characteristic of rheumatic fever that failure to respond within 48 hours should prompt reconsideration of the diagnosis 3.

Transition Phase: Low-Dose Aspirin (Antiplatelet)

Dosing and rationale:

• After fever resolution, reduce to 3–5 mg/kg/day as a single daily dose 1, 2
• This low-dose regimen provides antiplatelet effects to prevent thrombotic complications during the ongoing inflammatory phase 1

Total Treatment Duration

Complete the full 12-week course:

• Continue aspirin therapy for a total of 12 weeks from illness onset, regardless of symptom resolution 2
• This extended duration is necessary to control the inflammatory process completely and prevent recurrence 2
• The 12-week total includes both the high-dose acute phase and the low-dose continuation phase 2

Essential Safety Monitoring

Hepatotoxicity surveillance:

• Monitor liver enzymes regularly, as aspirin-mediated hepatic dysfunction occurs frequently in rheumatic fever patients 4
• Mild, transient hepatic abnormalities occur in approximately 64% of adults with rheumatic fever, though these are often disease-related rather than aspirin-induced 3

Reye syndrome prevention:

• Discontinue aspirin immediately if influenza or varicella infection develops 1, 5
• Substitute clopidogrel or low-molecular-weight heparin during these viral illnesses to maintain antithrombotic coverage 1, 5
• Administer annual influenza vaccination to all patients on long-term aspirin therapy 1, 5

Drug interactions:

• Never co-administer ibuprofen with aspirin, as ibuprofen completely antagonizes aspirin's antiplatelet effects 1, 5

Alternative Therapy Option

Naproxen as aspirin substitute:

• If aspirin is not tolerated, naproxen 10–20 mg/kg/day is equally effective for arthritis control 4
• Naproxen produces equivalent time to arthritis resolution (mean 2.9 days) with significantly fewer liver enzyme elevations compared to aspirin (P=0.002) 4
• Naproxen offers easier dosing (twice daily vs. four times daily) and improved safety profile 4

Common Pitfalls to Avoid

• Do not stop aspirin when arthritis resolves early: Symptoms typically improve within 2–3 days, but the full 12-week course is required to prevent recurrence 2
• Do not use analgesic doses (≤3,900 mg/day in adults): Only high anti-inflammatory doses provide therapeutic benefit in rheumatic fever 6
• Do not confuse with Kawasaki disease protocols: Rheumatic fever requires 12 weeks total duration, whereas Kawasaki disease without coronary abnormalities requires only 6–8 weeks 1, 2

Secondary Prophylaxis (After Acute Treatment)

Long-term prevention of recurrence:

• After completing the 12-week acute treatment course, initiate secondary prophylaxis with benzathine penicillin G 1.2 million units IM every 3–4 weeks 2
• Secondary prophylaxis is distinct from acute treatment and continues for years based on cardiac involvement status 2
• Low-dose aspirin is not used for secondary prophylaxis; penicillin is the agent of choice 2